Effects of Physiotherapy in Patients with Alzheimer's Disease: Analysis of the Intervention Methodology and Determination of the most Effective Degree of Involvement

Abstract

The World Health Organization (WHO) estimates that currently more than 55 million people are living with dementia, accounting for 8.1% of women and 5.4% of men over the age of 65. Of these, approximately 10.3 million are in the Region of the Americas. This article examines the relevance and effectiveness of physiotherapy in the treatment of Alzheimer's disease (AD), focusing on how physiotherapy can impact the quality of life of individuals affected by AD at different stages of the disease. The methodology centered on data collection through reliable and relevant databases, ensuring the integrity of the research. Studies including individuals diagnosed with AD and cognitive assessments were examined. The results highlight the importance of tailoring physiotherapy treatments to the individual needs of patients based on their disease stage. Factors such as age, gender, and disease duration that may influence the response to physiotherapy in the context of AD were also explored. The article emphasized the need for future research, public awareness, and the development of specific physiotherapy protocols to more effectively address this neurodegenerative disease. It also concludes that physiotherapy plays a fundamental role in the treatment of Alzheimer's disease, as it can help maintain and improve the quality of life of affected individuals.